![Paul Stone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Stone
Geschäftsführer bei 5AM Venture Management LLC
Vermögen: 4 Mio $ am 31.05.2024
Aktive Positionen von Paul Stone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Geschäftsführer | 26.03.2010 | - |
General Counsel | 26.03.2010 | - | |
Private Equity Investor | 01.01.2016 | - |
Karriereverlauf von Paul Stone
Ehemalige bekannte Positionen von Paul Stone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IDEAYA BIOSCIENCES, INC. | Geschäftsführer | 01.05.2018 | 09.07.2019 |
Finanzdirektor/CFO | 09.07.2019 | 10.11.2023 | |
Investor Relations Kontakt | - | 10.11.2023 | |
Public Communications Contact | 01.05.2018 | 10.11.2023 | |
General Counsel | 01.05.2018 | 09.07.2019 | |
Q32 BIO INC. | Direktor/Vorstandsmitglied | 01.03.2015 | 01.12.2015 |
CIDARA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2012 | 01.05.2014 |
Ethos Pharmaceuticals, Inc.
![]() Ethos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethos Pharmaceuticals, Inc. used to develop peptide drugs. The company had operations in Philadelphia and Charlottesville. The company was headquartered in San Francisco, CA. | General Counsel | 01.10.2007 | 01.03.2009 |
Ilypsa, Inc.
![]() Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01.04.2005 | 01.10.2007 |
Symyx Technologies, Inc.
![]() Symyx Technologies, Inc. Packaged SoftwareTechnology Services Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01.12.1998 | 01.04.2005 |
Senniger Powers LLP
![]() Senniger Powers LLP Miscellaneous Commercial ServicesCommercial Services Senniger Powers LLP provides legal services. It offers pro bono services, patents, and litigation services. The company is headquartered in St. Louis, MO. | Corporate Officer/Principal | 01.01.1995 | 01.01.1998 |
Save the Bay | Direktor/Vorstandsmitglied | - | - |
░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Paul Stone
University of Wisconsin | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Operativ
Director/Board Member | 4 |
General Counsel | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IDEAYA BIOSCIENCES, INC. | Health Technology |
CIDARA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Ethos Pharmaceuticals, Inc.
![]() Ethos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethos Pharmaceuticals, Inc. used to develop peptide drugs. The company had operations in Philadelphia and Charlottesville. The company was headquartered in San Francisco, CA. | Health Technology |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
Ilypsa, Inc.
![]() Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
Symyx Technologies, Inc.
![]() Symyx Technologies, Inc. Packaged SoftwareTechnology Services Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA. | Technology Services |
The Assay Depot, Inc.
![]() The Assay Depot, Inc. Miscellaneous Commercial ServicesCommercial Services The Assay Depot, Inc. operates as a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. It serves large and small pharmaceutical companies, government institutes, biotechnology companies, academic researchers and citizen scientists. The company was founded by Christopher L. Petersen, Andrew B. Martin, and Kevin D. Lustig in 2007 and is headquartered in Solana Beach, CA. | Commercial Services |
Senniger Powers LLP
![]() Senniger Powers LLP Miscellaneous Commercial ServicesCommercial Services Senniger Powers LLP provides legal services. It offers pro bono services, patents, and litigation services. The company is headquartered in St. Louis, MO. | Commercial Services |
Homology Medicines, Inc.
![]() Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Save the Bay |
- Börse
- Insiders
- Paul Stone
- Erfahrung